Tag: DMARD (disease modifying antirheumatic drug)

Study Informs About Risks of Discontinuing Meds in JIA

Many but not all children with juvenile idiopathic arthritis (JIA) can regain remission after stopping and then restarting treatment, according to preliminary data from the...

Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds

Psoriasis patients treated with biological disease-modifying antirheumatic drugs had a significantly lower incidence of psoriatic arthritis (PsA) compared with those treated with phototherapy, in a...

Nintedanib Slows Interstitial Lung Disease in Patients With RA

In a new subgroup analysis of a previously published multinational trial, the preservation of lung function with nintedanib (Ofev) was about the same in patients...

Patients With Early Arthritis May Need Tailored Treatments

Patients with early, undifferentiated arthritis may benefit from milder or stronger treatments, depending on the number of their risk factors for developing rheumatoid arthritis, researchers...

Methotrexate Users Need Tuberculosis Tests in High-TB Areas

People taking even low-dose methotrexate need tuberculosis screening and ongoing clinical care if they live in areas where TB is common, results of a study...